Developing new treatments to combat bacterial resistance
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
This study is working on new treatments to help fight stubborn bacterial infections that don't respond to regular antibiotics, using advanced technology to create special medicines that could help patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Allucent Government Services (Us) LLC NIH-funded |
| Lab location | 1 site (Cary, United States) |
| Project ID | NIH-10934772 on NIH RePORTER |
What this research studies
This research focuses on the preclinical development of biopharmaceutical products aimed at addressing antibacterial resistance. It utilizes advanced biotechnology processes to create materials such as monoclonal antibodies, recombinant proteins, and small interfering RNA (siRNA) vectors. The program includes comprehensive services like product development planning, assay development, and regulatory support to ensure effective translation of these products into clinical settings. Patients may benefit from innovative therapies that target resistant bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from infections that are resistant to standard antibiotic treatments.
Not a fit: Patients with infections that are not caused by antibiotic-resistant bacteria may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Other research has shown promise in developing biopharmaceuticals targeting bacterial resistance, indicating a potential for success in this area.
Where this research is happening
Cary, United States
- Allucent Government Services (Us) LLC — Cary, United States (Active)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.